Genscript Biotech Corporation

OTCPK:GNNS.F Stock Report

Market Cap: US$2.9b

Genscript Biotech Future Growth

Future criteria checks 5/6

Genscript Biotech is forecast to grow earnings and revenue by 112.7% and 39.9% per annum respectively. EPS is expected to grow by 112.5% per annum. Return on equity is forecast to be 9.5% in 3 years.

Key information

112.7%

Earnings growth rate

112.5%

EPS growth rate

Life Sciences earnings growth18.4%
Revenue growth rate39.9%
Future return on equity9.5%
Analyst coverage

Good

Last updated23 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:GNNS.F - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,680255-4977811
12/31/20251,80942-2009712
12/31/20241,200-170-330-9912
6/30/20241,010-177-276-20N/A
3/31/2024925-136-410-153N/A
12/31/2023840-95-543-287N/A
9/30/2023773-140-506-266N/A
6/30/2023707-185-523-245N/A
3/31/2023667-206-431-183N/A
12/31/2022626-227-339-120N/A
9/30/2022598-315-321-142N/A
6/30/2022570-403-304-163N/A
3/31/2022530-381-289-150N/A
12/31/2021490-359-274-137N/A
9/30/2021483-265-265-127N/A
6/30/2021454-183-256-118N/A
3/31/2021422-194-268-134N/A
12/31/2020391-205-279-151N/A
9/30/2020354-194-171-48N/A
6/30/2020318-183-6454N/A
3/31/2020296-140-10312N/A
12/31/2019273-97-142-30N/A
9/30/2019257-59-207-116N/A
6/30/2019241-22-272-202N/A
3/31/20192360-1853N/A
12/31/201823121236308N/A
9/30/201821624266338N/A
6/30/201820127297369N/A
3/31/201817726N/A195N/A
12/31/201715326N/A21N/A
9/30/201713927N/A24N/A
6/30/201712528N/A27N/A
3/31/201712027N/A30N/A
12/31/201611526N/A33N/A
9/30/201610726N/A29N/A
6/30/20169925N/A25N/A
3/31/20169321N/A22N/A
12/31/20158718N/A20N/A
9/30/20158213N/A18N/A
6/30/2015788N/A16N/A
3/31/2015747N/A14N/A
12/31/2014706N/A12N/A
12/31/2013606N/A12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GNNS.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: GNNS.F is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: GNNS.F is expected to become profitable in the next 3 years.

Revenue vs Market: GNNS.F's revenue (39.9% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: GNNS.F's revenue (39.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: GNNS.F's Return on Equity is forecast to be low in 3 years time (9.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y